Dermatology
Latest News
More Illnesses Possible Related Linked to Counterfeit Botulinum Toxin Reported
This report follows a CDC advisory published in April 2024 of at least 22 people from 11 states who reported serious reactions after receiving...
Latest News
Study Finds Potential benefits of Spironolactone for Women with HS
The retrospective study included 157 women with HS who received spironolactone for at least 3 months.
Latest News
Studies Show Dupilumab Effects In Children with Both Atopic Dermatitis and Alopecia
Overall, 77.4% of patients in the trials achieved hair regrowth with dupilumab treatment.
Latest News
Study Estimates Global Prevalence of Seborrheic Dermatitis
The global prevalence in this meta-analysis was “higher than previous large-scale global estimates,’ the authors wrote.
Latest News
How Common Are Life-Threatening Infections In Infants with Pustules, Vesicles?
Among 879 consults, 183 afebrile infants were identified as having presented with pustules, vesicles, and/or bullae.
Latest News
Topical PDE4 Inhibitor Now Approved for Atopic Dermatitis in Children, Adults
Among children and adults who participated in the INTEGUMENT studies for 28 and 56 weeks, 61.3% and 65.7% saw a 75% reduction in their Eczema Area...
Latest News
Dupilumab Safe, Effective Over 5 Years in Moderate to Severe Atopic Dermatitis
Serious and severe treatment-emergent adverse event rates were 10.6% and 10.0%, respectively.
Latest News
Cosmetic Botulinum Toxin A Doses May Differ in Sunny Climates
“Functional musculature differences may arise from chronic behavioral adjustment to high sun exposure levels, requiring greater doses,” the study...
From the Journals
Urticaria Linked to Higher Cancer Risk, Study Finds
Researchers compare the incident cancer risk between patients with urticaria and the general population using data from Danish healthcare...
Latest News
Survey Highlights Real-World Use of Upadacitinib in Adults With Atopic Dermatitis
Nearly all experienced improvements in itch, with 86.8% reporting “very much” or “much” improved itch.
Latest News
Small Melanoma In Situ: Single Center Study Finds Recurrence Low With 5-mm Margin Excisions
“This study demonstrated a comparable 0.9% recurrence rate achieved with a conservative 5-mm excisional margin,” the authors reported.